Non-standard amino acid containing compositions and uses thereof
Abstract
Provided herein is a stabilized DNase I polypeptide containing a non-standard amino acid that maintains enzymatic activity even under harsh conditions, such as reducing environments. The stabilized DNase I polypeptide has enzymatic activity in reducing environments that is higher than a corresponding DNase I polypeptide without the non-standard amino acids under the same conditions. Also provided herein are polynucleotides encoding the stabilized DNase I polypeptide, cells for expressing and/or producing the stabilized DNase I polypeptide, and methods of use of the stabilized DNase I polypeptide.
Claims
exact text as granted — not AI-modified1 .- 83 . (canceled)
84 . A method of making a composition comprising a deoxyribonuclease I (DNase I) polypeptide comprising at least 80% sequence identity to at least 225 contiguous amino acids of the polypeptide of SEQ ID NO: 1, wherein the DNase I polypeptide comprises from two to four selenocysteines, wherein the DNase I polypeptide comprises a first pair of selenocysteines linked by a first diselenide bond, wherein at least two of said two to four selenocysteines are located at positions selected from the group consisting of:
(a) a position corresponding to position 102 of the polypeptide of SEQ ID NO:1, (b) a position corresponding to position 105 of the polypeptide of SEQ ID NO: 1, (c) a position corresponding to position 174 of the polypeptide of SEQ ID NO:1, and (d) a position corresponding to position 210 of the polypeptide of SEQ ID NO:1;
wherein the method comprises expressing the DNase I polypeptide in a bacterial cell.
85 . The method of claim 84 , wherein the DNase I polypeptide further comprises a second pair of selenocysteines linked by a second diselenide bond.
86 . The method of claim 84 , wherein the DNase I polypeptide comprises a sequence with at least 90% sequence identity to at least 225 contiguous amino acids of the polypeptide of SEQ ID NO: 1.
87 . The method of claim 84 , wherein the DNase I polypeptide comprises a sequence with at least 95% sequence identity to at least 225 contiguous amino acids of the polypeptide of SEQ ID NO: 1.
88 . The method of claim 84 , wherein the DNase I polypeptide has at least 90% sequence identity to the polypeptide of SEQ ID NO:1.
89 . The method of claim 84 , wherein the DNase I polypeptide comprises four selenocysteines, wherein the four selenocysteines are located at the following positions:
(a) a position corresponding to position 102 of the polypeptide of SEQ ID NO:1, (b) a position corresponding to position 105 of the polypeptide of SEQ ID NO: 1, (c) a position corresponding to position 174 of the polypeptide of SEQ ID NO: 1, and (d) a position corresponding to position 210 of the polypeptide of SEQ ID NO:1.
90 . The method of claim 84 , wherein the DNase I polypeptide comprises a selenocysteine at a position corresponding to position 102 of the polypeptide of SEQ ID NO:1 linked by a diselenide bond to a selenocysteine at a position corresponding to position 105 of the polypeptide of SEQ ID NO:1.
91 . The method of claim 84 , wherein the DNase I polypeptide comprises a selenocysteine at a position corresponding to position 174 of the polypeptide of SEQ ID NO:1 linked by a diselenide bond to a selenocysteine at a position corresponding to position 210 of the polypeptide of SEQ ID NO:1.
92 . The method of claim 84 , wherein the DNase I polypeptide is recombinant.
93 . The method of claim 84 , wherein the DNase I polypeptide is a modified bovine DNase I.
94 . The method of claim 84 , wherein the bacterial cell is a genomically recoded bacterial cell.
95 . The method of claim 84 , wherein the method further comprises purifying the DNase I polypeptide.
96 . The method of claim 84 , wherein the method comprises culturing the bacterial cell under conditions in which the amino acid sequence of the DNase I polypeptide is expressed.
97 . A method of cleaving or fragmenting a DNA substrate comprising:
contacting a deoxyribonuclease I (DNase I) polypeptide to a DNA substrate; wherein the DNase I polypeptide comprises at least 80% sequence identity to at least 225 contiguous amino acids of the polypeptide of SEQ ID NO: 1, wherein the DNase I polypeptide comprises from two to four selenocysteines, wherein the DNase I polypeptide comprises a first pair of selenocysteines linked by a first diselenide bond, and wherein at least two of said two to four selenocysteines are located at positions selected from the group consisting of:
(a) a position corresponding to position 102 of the polypeptide of SEQ ID NO: 1,
(b) a position corresponding to position 105 of the polypeptide of SEQ ID NO: 1,
(c) a position corresponding to position 174 of the polypeptide of SEQ ID NO:1, and
(d) a position corresponding to position 210 of the polypeptide of SEQ ID NO: 1.
98 . The method of claim 97 , wherein the DNA substrate is genomic DNA.
99 . The method of claim 97 , wherein the DNA substrate is from a single cell.
100 . The method of claim 99 , wherein the method comprises forming a plurality of vessels, wherein each vessel of the plurality of vessels comprises:
(a) a single cell; (b) the DNase I polypeptide; and (c) a buffer.
101 . The method of claim 100 , wherein the buffer is a lysis buffer and the method further comprises lysing the single cell, thereby releasing the DNA substrate from the single cell.
102 . The method of claim 101 , wherein the method further comprises barcoding the DNA substrate or fragments thereof.
103 . The method of claim 97 , wherein the DNA substrate is in a buffer or attached to a solid surface.Join the waitlist — get patent alerts
Track US2023257724A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.